Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Independent committee recommends early end to phase III Velcade trial

Dec. 17, 2003

Japanese rights to bevacizumab and pertuzumab licensed to Chugai

Dec. 17, 2003

Targent acquires dibromodulcitol

Dec. 17, 2003

Novacea licenses North American rights to AQ4N

Dec. 17, 2003

Praecis collaborates with NCI on PPI-2458

Dec. 16, 2003

Avanir and Peregrine execute license agreement for antibody

Dec. 16, 2003

Phase I trial commences for CNTO-95

Dec. 16, 2003

Monoclonal antibody targeting CD44 induces differentiation and apoptosis in AML cells

Dec. 15, 2003

EiRx to evaluate SR Pharma's inositol phosphoglycans

Dec. 15, 2003

Novel Pin1 inhibitors designed and tested by German researchers

Dec. 15, 2003

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...